The global embolic protection devices market size was estimated to be USD 0.604 billion in 2023 and is expected to reach at USD 1.35 billion by 2034 with a CAGR of 8.37% during the forecast period 2024-2034. Growing prevalence of cardiovascular & neurovascular disorders, surge in investments for the development of technologically advanced embolic protection devices, increasing demand for minimally invasive procedures, rising number of transcatheter aortic valve replacement procedures, growing awareness regarding embolic devices, surge in technological advancements in embolic protection devices, increasing product launches, and rising number of clinical trial procedures regarding transcatheter aortic valve replacement procedures are some of the key factors boosting the market growth.
Rising number of clinical trial procedures regarding transcatheter aortic valve replacement procedures is predicted to boost the market growth during the forecast period. A narrowed aortic valve that doesn't open correctly can be substituted using a less invasive procedure known as transcatheter aortic valve replacement. Hence, market players are focusing on development of advanced devices. For instance, in September 2022, Boston Scientific Corporation has released the findings of a clinical trial involving the PROTECTED TAVR, which aimed to evaluate the effectiveness of the SENTINEL Cerebral Protection System. This system is designed to capture and remove embolic debris during the replacement of the transcatheter aortic valve, preventing it from reaching the brain and potentially causing a stroke. These developments have not only enhanced the company's reputation but also expanded its customer base.
By product, distal occlusion systems was the highest revenue-grossing segment in the global embolic protection devices market in 2023 owing to the availability of these filters in a variety of parameters, the simplicity of usage, lack of obstruction to lesion imaging, reduced bridge profiles, & fewer space needs for accusatory balloons, and surge in number of neurovascular surgeries. Additionally, distal filter is predicted to grow at fastest CAGR during the forecast period owing to the benefit offered by the distal filters, such as the ease of usage accessibility in a range of circumstances and absence of interference with lesion vision and growing approvals by regulatory authorities. For instance, in July 2023, Imperative Care has received FDA 510(k) clearance for its Zoom 88 large distal platform (LDP) support, thereby broadening its range of 0.088-inch intracranial access options. The company combines this 0.088-inch intracranial access technology with angled-tip aspiration catheters to facilitate reperfusion in stroke interventions.
By application, cardiovascular diseases was the highest revenue-grossing segment in the global embolic protection devices market in 2023 owing to the increasing prevalence of cardiovascular disorders such as coronary artery disease, arrhythmia, & stroke, rising geriatric population, growing approvals by regulatory bodies, and surge in launch of advanced technologies. For instance, in June 2022, Conformal Medical Inc, a medical device firm focused on advancing next-gen LAAO technology, has initiated the CONFORM pivotal trial by enrolling its initial patients at two U.S. locations. This investigational device exemption (IDE) study is intended to assess the safety and effectiveness of the CLAAS® System developed by the company, in comparison to LAAO devices already on the market. The goal is to provide data to support pre-market approval by the U.S. Food and Drug Administration (FDA). Additionally, neurovascular diseases is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of neurovascular diseases, surge in demand for embolic protection devices for the treatment, and rising awareness regarding minimally invasive procedures.
By end-user, hospitals was the highest revenue-grossing segment in the global embolic protection devices market in 2023 owing to the surge in number of angioplasty procedures performed within hospitals, increasing prevalence of chronic vascular diseases, and rising research & development activities. For instance, in May 2022, Filterlex Medical has shared the findings from an initial human study, which showed that the Captis device, a comprehensive embolic protection device designed to minimize the likelihood of stroke and other complications during procedures involving the left heart, is both safe and effective, as well as technically viable. Additionally, ambulatory care centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing initiatives to provide quality treatment for cardiovascular diseases and rising technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of cardiovascular disorders, growing investments for the development of advanced embolic protection devices, rising demand for minimally invasive procedures, and increasing number of clinical trial procedures. For instance, in March 2022, Innovative Cardiovascular Solutions funded a clinical investigation aimed at assessing the safety, efficacy, and functionality of the EMBLOK embolic protection systems (EPS) in transcatheter aortic valve replacement (TAVR), comparing it through randomization with an embolic protection device already available in the market. Additionally, Europe region is predicted to grow at fastest CAGR during the forecast period owing to the increasing transcatheter aortic valve replacement procedures, growing technological advancements in embolic protection devices, and rising introduction of advanced products. For instance, in April 2023, Ahlstrom has introduced Ahlstrom ECO, an automotive filter media derived from renewable lignin. Ahlstrom ECO represents a technological solution that addresses the growing sustainability requirements within the global transportation sector, providing filter manufacturers with an alternative option.
Rising number of clinical trial procedures regarding transcatheter aortic valve replacement procedures is predicted to boost the market growth during the forecast period. A narrowed aortic valve that doesn't open correctly can be substituted using a less invasive procedure known as transcatheter aortic valve replacement. Hence, market players are focusing on development of advanced devices. For instance, in September 2022, Boston Scientific Corporation has released the findings of a clinical trial involving the PROTECTED TAVR, which aimed to evaluate the effectiveness of the SENTINEL Cerebral Protection System. This system is designed to capture and remove embolic debris during the replacement of the transcatheter aortic valve, preventing it from reaching the brain and potentially causing a stroke. These developments have not only enhanced the company's reputation but also expanded its customer base.
By product, distal occlusion systems was the highest revenue-grossing segment in the global embolic protection devices market in 2023 owing to the availability of these filters in a variety of parameters, the simplicity of usage, lack of obstruction to lesion imaging, reduced bridge profiles, & fewer space needs for accusatory balloons, and surge in number of neurovascular surgeries. Additionally, distal filter is predicted to grow at fastest CAGR during the forecast period owing to the benefit offered by the distal filters, such as the ease of usage accessibility in a range of circumstances and absence of interference with lesion vision and growing approvals by regulatory authorities. For instance, in July 2023, Imperative Care has received FDA 510(k) clearance for its Zoom 88 large distal platform (LDP) support, thereby broadening its range of 0.088-inch intracranial access options. The company combines this 0.088-inch intracranial access technology with angled-tip aspiration catheters to facilitate reperfusion in stroke interventions.
By application, cardiovascular diseases was the highest revenue-grossing segment in the global embolic protection devices market in 2023 owing to the increasing prevalence of cardiovascular disorders such as coronary artery disease, arrhythmia, & stroke, rising geriatric population, growing approvals by regulatory bodies, and surge in launch of advanced technologies. For instance, in June 2022, Conformal Medical Inc, a medical device firm focused on advancing next-gen LAAO technology, has initiated the CONFORM pivotal trial by enrolling its initial patients at two U.S. locations. This investigational device exemption (IDE) study is intended to assess the safety and effectiveness of the CLAAS® System developed by the company, in comparison to LAAO devices already on the market. The goal is to provide data to support pre-market approval by the U.S. Food and Drug Administration (FDA). Additionally, neurovascular diseases is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of neurovascular diseases, surge in demand for embolic protection devices for the treatment, and rising awareness regarding minimally invasive procedures.
By end-user, hospitals was the highest revenue-grossing segment in the global embolic protection devices market in 2023 owing to the surge in number of angioplasty procedures performed within hospitals, increasing prevalence of chronic vascular diseases, and rising research & development activities. For instance, in May 2022, Filterlex Medical has shared the findings from an initial human study, which showed that the Captis device, a comprehensive embolic protection device designed to minimize the likelihood of stroke and other complications during procedures involving the left heart, is both safe and effective, as well as technically viable. Additionally, ambulatory care centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing initiatives to provide quality treatment for cardiovascular diseases and rising technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of cardiovascular disorders, growing investments for the development of advanced embolic protection devices, rising demand for minimally invasive procedures, and increasing number of clinical trial procedures. For instance, in March 2022, Innovative Cardiovascular Solutions funded a clinical investigation aimed at assessing the safety, efficacy, and functionality of the EMBLOK embolic protection systems (EPS) in transcatheter aortic valve replacement (TAVR), comparing it through randomization with an embolic protection device already available in the market. Additionally, Europe region is predicted to grow at fastest CAGR during the forecast period owing to the increasing transcatheter aortic valve replacement procedures, growing technological advancements in embolic protection devices, and rising introduction of advanced products. For instance, in April 2023, Ahlstrom has introduced Ahlstrom ECO, an automotive filter media derived from renewable lignin. Ahlstrom ECO represents a technological solution that addresses the growing sustainability requirements within the global transportation sector, providing filter manufacturers with an alternative option.
Segmentation: Embolic Protection Devices Market Report 2022 - 2033
Embolic Protection Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Proximal Occlusion Filters
- Distal Filters
- Distal Occlusion Filters
Embolic Protection Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Peripheral Vascular Diseases
- Neurovascular Diseases
- Cardiovascular Diseases
- Transcatheter Aortic Valve Replacement
- Carotid Artery Diseases Saphenous Vein Graft Disease
- Percutaneous Coronary Intervention
Embolic Protection Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Care Centers
Embolic Protection Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Embolic Protection Devices Market: Product Estimates & Trend Analysis
8. Embolic Protection Devices Market: Application Estimates & Trend Analysis
9. Embolic Protection Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Embolic Protection Devices Market
12. Europe Global Embolic Protection Devices Market
13. Asia Pacific Global Embolic Protection Devices Market
14. Latin America Global Embolic Protection Devices Market
15. MEA Global Embolic Protection Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Filterlex Medical
- Andioslide
- Innovative Cardiovascular Solutions
- Silk Road Medical
- Conformal Medical Inc
- Contego Medical
- Imperative Care
- Cordis (A Cardinal Health Company)
- Medtronic
- Abbott
- Allium Medical Solutions
- W.L. Gore & Associates
- Claret Medical.
